CRVO 25 year old man - Factor V Leiden Heterozygous
|
|
25 year old man with 1 week vision loss 20/16 OD 20/100 OS - CRVO
Heterozyrous for Factor V Leiden - Required 3 years of Lucentis - VA improved to 20/30. Able to stop therapy
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 443 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 358 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 416 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 357 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 390 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 365 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 425 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 370 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 377 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 357 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 364 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 366 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 376 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 355 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 377 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 363 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 342 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 384 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 365 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 321 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 340 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 376 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 366 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 401 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 345 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|
|
|
|
|
|
25 year old man with 1 week vision loss 20/16 OD 20/100 OS - CRVO
Heterozyrous for Factor V Leiden - Required 3 years of Lucentis - VA improved to 20/30. Able to stop therapy